UGCG and cancer: Across cancer models, UGCG overexpression correlates with poor chemotherapy response, and its inhibition can restore drug sensitivity.5 Thus, UGCG acts as both an immune checkpoint and a chemoresistance engine, making it a uniquely strategic metabolic target.